Warren Stone - 13 Jan 2026 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Pres & Chief Operating Officer
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
13 Jan 2026
Net transactions value
$0
Form type
4
Filing time
15 Jan 2026, 16:22:44 UTC
Previous filing
03 Dec 2025
Next filing
21 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stone Warren Pres & Chief Operating Officer 9490 NEOGENOMICS WAY, FORT MYERS /s/ Ali Olivo, Attorney-in-Fact 15 Jan 2026 0001955295

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +59,382 +60% $0.000000 158,886 13 Jan 2026 Direct F1
transaction NEO Common Stock Tax liability $0 -15,127 -9.5% $0.000000 143,759 13 Jan 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 166,113 13 Jan 2026 Common Stock 166,113 $11.21 Direct F3
holding NEO Stock Option (Right to Buy) 53,969 13 Jan 2026 Common Stock 53,969 $19.65 Direct F4
holding NEO Performance Stock Unit 21,204 13 Jan 2026 Common Stock 21,204 $0.000000 Direct F5, F6
holding NEO Restricted Stock Unit 9,613 13 Jan 2026 Common Stock 9,613 $0.000000 Direct F6, F7
holding NEO Stock Option (Right to Buy) 42,344 13 Jan 2026 Common Stock 42,344 $16.45 Direct F8
holding NEO Restricted Stock Unit 16,886 13 Jan 2026 Common Stock 16,886 $0.000000 Direct F6, F9
holding NEO Performance Stock Unit 25,330 13 Jan 2026 Common Stock 25,330 $0.000000 Direct F6, F10
holding NEO Stock Option (Right to Buy) 29,976 13 Jan 2026 Common Stock 29,976 $13.96 Direct F11
holding NEO Restricted Stock Unit 17,908 13 Jan 2026 Common Stock 17,908 $0.000000 Direct F6, F12
holding NEO Performance Stock Unit 17,908 13 Jan 2026 Common Stock 17,908 $0.000000 Direct F6, F13
holding NEO Restricted Stock Unit 59,382 13 Jan 2026 Common Stock 59,382 $0.000000 Direct F6
holding NEO Stock Option (Right to Buy) 143,266 13 Jan 2026 Common Stock 143,266 $13.05 Direct F14, F15
holding NEO Restricted Stock Unit 84,317 13 Jan 2026 Common Stock 84,317 $0.000000 Direct F6, F16
holding NEO Stock Option (Right to Buy) 94,518 13 Jan 2026 Common Stock 94,518 $10.44 Direct F17, F18
holding NEO Restricted Stock Unit 52,687 13 Jan 2026 Common Stock 52,687 $0.000000 Direct F6, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2 Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F3 On December 1, 2022, Mr. Stone was granted 166,113 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4 On May 11, 2023, Mr. Stone was granted 53,969 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F5 On May 11, 2023, Mr. Stone was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
F6 Once vested, the shares of common stock are not subject to expiration.
F7 On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F8 On February 23, 2024, Mr. Stone was granted 42,344 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F9 On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F10 On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F11 On May 2, 2024, Mr. Stone was granted 29,976 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F12 On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F13 On May 2, 2024, Mr. Stone was granted 17,908 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is26,862. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F14 This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%
F15 On February 21, 2025, Mr. Stone was granted 143,266 stock options. At the time of the grant, the options vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone's promotion to President &Chief Operating Officer on April 1, 2025, the vesting schedule of these options was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
F16 On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone'spromotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate.
F17 This stock option was granted as a premnium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%.
F18 On April 1, 2025, Mr. Stone was granted 94,518 stock options. The options vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.
F19 On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date.